Suppr超能文献

国家阿尔茨海默病协调中心的统一数据集第 3 版。

Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set.

机构信息

Department of Epidemiology, National Alzheimer's Coordinating Center, University of Washington, Seattle, WA.

Institute for Healthy Aging and Lifespan Studies and School of Urban and Regional Planning, Florida Atlantic University, Boca Raton, FL.

出版信息

Alzheimer Dis Assoc Disord. 2018 Oct-Dec;32(4):351-358. doi: 10.1097/WAD.0000000000000279.

Abstract

INTRODUCTION

In 2015, the US Alzheimer's Disease Centers (ADC) implemented Version 3 of the Uniform Data Set (UDS). This paper describes the history of Version 3 development and the UDS data that are freely available to researchers.

METHODS

UDS Version 3 was developed after years of coordination between the National Institute on Aging-appointed Clinical Task Force (CTF), clinicians from ∼30 ADCs, and the National Alzheimer's Coordinating Center (NACC). The CTF recognized the need for updates to align with the state of the science in dementia research, while being flexible to the diverse needs and diseases studied at the ADCs. Version 3 also developed a nonproprietary neuropsychological battery.

RESULTS

This paper focuses on the substantial Version 3 changes to the UDS forms related to clinical diagnosis and characterization of clinical symptoms to match updated consensus-based diagnostic criteria. Between March 2015 and March 2018, 4820 participants were enrolled using UDS Version 3. Longitudinal data were available for 25,337 of the 37,568 total participants using all UDS versions.

DISCUSSION

The results from utilization of the UDS highlight the possibility for numerous research institutions to successfully collaborate, produce, and use standardized data collection instruments for over a decade.

摘要

简介

2015 年,美国阿尔茨海默病中心(ADC)实施了统一数据集(UDS)第 3 版。本文描述了第 3 版的开发历史以及可供研究人员免费使用的 UDS 数据。

方法

UDS 第 3 版是在国家老龄化研究所任命的临床工作组(CTF)、来自约 30 个 ADC 的临床医生以及国家阿尔茨海默病协调中心(NACC)多年协调之后开发的。CTF 认识到需要更新,以与痴呆症研究的科学现状保持一致,同时灵活适应 ADC 研究的不同需求和疾病。第 3 版还开发了一个非专利性的神经心理学电池。

结果

本文重点介绍了 UDS 表单在临床诊断和临床症状特征方面的重大第 3 版变更,以匹配基于共识的更新诊断标准。2015 年 3 月至 2018 年 3 月,使用 UDS 第 3 版共招募了 4820 名参与者。使用所有 UDS 版本,共有 37568 名参与者中的 25337 名参与者提供了纵向数据。

讨论

UDS 的使用结果表明,许多研究机构可以成功合作,制作和使用标准化的数据收集工具超过十年。

相似文献

1
Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set.
Alzheimer Dis Assoc Disord. 2018 Oct-Dec;32(4):351-358. doi: 10.1097/WAD.0000000000000279.
2
The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set.
Alzheimer Dis Assoc Disord. 2007 Jul-Sep;21(3):249-58. doi: 10.1097/WAD.0b013e318142774e.
3
The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):210-6. doi: 10.1097/01.wad.0000213865.09806.92.
4
Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS).
Alzheimer Dis Assoc Disord. 2018 Jan-Mar;32(1):10-17. doi: 10.1097/WAD.0000000000000223.
5
The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery.
Alzheimer Dis Assoc Disord. 2009 Apr-Jun;23(2):91-101. doi: 10.1097/WAD.0b013e318191c7dd.
7
The Spanish translation and adaptation of the Uniform Data Set of the National Institute on Aging Alzheimer's Disease Centers.
Alzheimer Dis Assoc Disord. 2009 Apr-Jun;23(2):102-9. doi: 10.1097/WAD.0b013e318193e376.
9
Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.
J Neuropathol Exp Neurol. 2012 Apr;71(4):266-73. doi: 10.1097/NEN.0b013e31824b211b.

引用本文的文献

3
Bayesian integration of longitudinal and survival outcomes in Alzheimer's disease prediction.
Alzheimers Dement. 2025 Sep;21(9):e70094. doi: 10.1002/alz.70094.
9
Intersecting vulnerabilities: Race, Depression, and White Matter Hyperintensity burden in Aging.
medRxiv. 2025 Jul 25:2025.07.24.25332172. doi: 10.1101/2025.07.24.25332172.
10
Identifying dementia neuropathology using low-burden clinical data.
Alzheimers Dement. 2025 Aug;21(8):e70539. doi: 10.1002/alz.70539.

本文引用的文献

1
The Revised National Alzheimer's Coordinating Center's Neuropathology Form-Available Data and New Analyses.
J Neuropathol Exp Neurol. 2018 Aug 1;77(8):717-726. doi: 10.1093/jnen/nly049.
2
Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout.
Int Psychogeriatr. 2018 Oct;30(10):1477-1487. doi: 10.1017/S1041610218000017. Epub 2018 Apr 18.
3
Pathologically Confirmed Alzheimer's Disease in APOE ɛ2 Homozygotes is Rare but Does Occur.
J Alzheimers Dis. 2018;62(4):1527-1530. doi: 10.3233/JAD-171060.
4
The nonlinear relationship between cerebrospinal fluid Aβ42 and tau in preclinical Alzheimer's disease.
PLoS One. 2018 Feb 7;13(2):e0191240. doi: 10.1371/journal.pone.0191240. eCollection 2018.
5
7
DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia.
Alzheimers Dement. 2018 May;14(5):664-679. doi: 10.1016/j.jalz.2017.11.010. Epub 2018 Jan 9.
8
The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment.
Alzheimer Dis Assoc Disord. 2018 Apr-Jun;32(2):120-124. doi: 10.1097/WAD.0000000000000240.
10
Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis.
Alzheimers Dement (N Y). 2017 Nov 26;4:1-10. doi: 10.1016/j.trci.2017.10.008. eCollection 2018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验